Spain· ES:1181340004
TAKHZYRO 300 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
A medicinal product containing lanadelumab, registered in Spain by Takeda Pharmaceuticals International Ag Ireland Branch.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- lanadelumab
- Manufacturer
- Takeda Pharmaceuticals International Ag Ireland Branch
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lanadelumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTAKHZYROTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- IcelandTakhzyroTakeda Pharmaceuticals International AG Ireland Branch
- BelgiumTakhzyro 300 mgTakeda Pharmaceuticals International Ireland Branch
- SwedenTAKHZYRO 300 mg Injektionsvätska, lösningTakeda Pharmaceuticals International AG Ireland Branch
- NorwayTakhzyroTakeda Pharmaceuticals International AG Ireland Branch
- PolandTakhzyroTakeda Pharmaceuticals International AG
- United StatesTAKHZYROTakeda Pharmaceuticals America, Inc.
- FinlandTakhzyroOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Takhzyro
- Liechtenstein · Takhzyro
- Norway · Takhzyro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b0531da9-76ea-44e3-8247-68482c8d900c GET /v1/drugs/b0531da9-76ea-44e3-8247-68482c8d900c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1599670298000}",
"nregistro": "1181340004",
"substance": "lanadelumab"
}See everything about lanadelumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.